Literature DB >> 31599424

MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.

Y Chen1, S-A Hao, Y Jiang, B Gao, W-G Tian, S Zhang, L-J Guo, L-L Wang, D-L Luo.   

Abstract

OBJECTIVE: The important role of microRNA-1271 (miR-1271) has been identified in human diseases and cancers. However, the biological function of miR-1271 remains ambiguous in papillary thyroid carcinoma (PTC). Therefore, the specific role of miR-1271 was investigated in PTC. PATIENTS AND METHODS: The expressions of miR-1271 and insulin receptor substrate 1 (IRS1) were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) assay. The protein expression of the genes was measured by Western blot analysis. The function of miR-1271 was investigated using methyl thiazolyl tetrazolium (MTT) and transwell assays. The Dual-Luciferase assay was used to observe the relationship between miR-1271 and IRS1.
RESULTS: MiR-1271 was downregulated in PTC tissues. Moreover, overexpression of miR-1271 suppressed migration, invasion and proliferation of PTC cells. Furthermore, IRS1 was indicated as a direct target gene of miR-1271 and knockdown of IRS1 inhibited cell migration, invasion and proliferation in PTC. In addition, miR-1271 inhibited the progression of PTC by targeting IRS1. Besides that, miR-1271 blocked the epithelial-mesenchymal transition (EMT) and protein kinase B (AKT) pathway in PTC.
CONCLUSIONS: MiR-1271 inhibited the progression of PTC by targeting IRS1 and blocking EMT and AKT pathway.

Entities:  

Year:  2019        PMID: 31599424     DOI: 10.26355/eurrev_201909_19015

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer.

Authors:  Mariusz Rogucki; Iwona Sidorkiewicz; Magdalena Niemira; Janusz Bogdan Dzięcioł; Angelika Buczyńska; Agnieszka Adamska; Katarzyna Siewko; Maria Kościuszko; Katarzyna Maliszewska; Anna Wójcicka; Jakub Supronik; Małgorzata Szelachowska; Joanna Reszeć; Adam Jacek Krętowski; Anna Popławska-Kita
Journal:  Cancers (Basel)       Date:  2022-05-28       Impact factor: 6.575

2.  microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway.

Authors:  Feng-Juan Han; Jia Li; Ying Shen; Ying Guo; Yi-Chao Liu; Yang Yu; Jia-Yue Xu; Shao-Xuan Liu; Yan-Hong Wang
Journal:  J Ovarian Res       Date:  2020-09-18       Impact factor: 4.234

3.  The Prognostic Value of MicroRNAs in Thyroid Cancers-A Systematic Review and Meta-Analysis.

Authors:  Cristina Alina Silaghi; Vera Lozovanu; Horatiu Silaghi; Raluca Diana Georgescu; Cristina Pop; Anca Dobrean; Carmen Emanuela Georgescu
Journal:  Cancers (Basel)       Date:  2020-09-12       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.